Arkema SA (AKE.PA)
71.99EUR
11:37am EDT
€-0.28 (-0.39%)
€72.27
€72.29
€72.40
€71.48
825,279
294,307
€87.77
€51.42
About
Overall
| Beta: | 1.71 |
| Market Cap (Mil.): | €4,537.40 |
| Shares Outstanding (Mil.): | 62.78 |
| Dividend: | 1.80 |
| Yield (%): | 2.49 |
Financials
| AKE.PA | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 16.81 | 20.12 | 18.88 |
| EPS (TTM): | 4.30 | -- | -- |
| ROI: | 6.39 | 8.59 | 16.90 |
| ROE: | 11.88 | 10.45 | 19.12 |
Arkema to book 125 mln euro charge for former unit
PARIS, April 10 - French chemicals maker Arkema will book a first-quarter charge of 125 million euros ($163 million) to reflect its exposure to unprofitable vinyls business Kem One, which it spun off in July 2012, Arkema said on Wednesday.
Spun-off Arkema unit begins bankruptcy proceedings
LYON, March 27 - A French commercial court on Wednesday opened bankruptcy proceedings for unprofitable chemicals-maker Kem One, which was spun off from France's Arkema in July and which employs 1,300 people, the court said.
GBL increases dividend as 2012 profits more than triple
BRUSSELS, March 5 - Belgian holding company Groupe Bruxelles Lambert said on Tuesday it would increase its full-year dividend by 2 percent to 2.65 euros ($3.45) per share after its earnings for 2012 more than tripled due to the benefits of divestments.
Klesch sues Arkema over vinyl unit sale
PARIS, March 4 - A Swiss investment group is suing specialist chemicals maker Arkema for 310 million euros ($403 million), in a dispute over its purchase of the French company's loss-making vinyl division last year.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Thomson Reuters StreetEvents
|
$75.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

